Sajulga, Emma .
HRN: 22-98-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
CEFUROXIME 1.5GM (VIAL)
06/02/2023
06/02/2023
IV
1.5 G
Loading Dose
Elective Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes